Compound 615
Identifiers
- Canonical SMILES:
OC(=O)[C@H](Cc1c[nH]cn1)NC(=O)c1c(F)cccc1F
- IUPAC name:
(2S)-2-[(2,6-difluorobenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid
- InChi:
InChI=1S/C13H11F2N3O3/c14-8-2-1-3-9(15)11(8)12(19)18-10(13(20)21)4-7-5-16-6-17-7/h1-3,5-6,10H,4H2,(H,16,17)(H,18,19)(H,20,21)/t10-/m0/s1
- InChiKey:
ULKWCLJACWMJSJ-JTQLQIEISA-N
External links
28124438 |
CHEMBL60732 |
23155975 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 6.70 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 295.08 g/mol | |||
HBA | 6 | |||
HBD | 3 | |||
HBA + HBD | 9 | |||
AlogP | -0.34 | |||
TPSA | 95.08 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6640 | Carnosine | DB11695 | |
0.5590 | ORE-1001 | DB12271 | |
0.5369 | Prezatide | DB11296 | |
0.5333 | Palmitoyl oligopeptide | DB11297 | |
0.5290 | Ipamorelin | DB12370 | |
0.5233 | TRV-120027 | DB12199 | |
0.5205 | Saralasin | DB06763 | |
0.5198 | Angiotensinamide | DB13517 | |
0.5175 | Cyclo(his-pro) | DB02414 | |
0.5170 | Histidine | DB00117 | |
0.5143 | Enalkiren | DB03395 | |
0.5103 | Protirelin | DB09421 | |
0.5084 | Angiotensin II | DB11842 | |
0.5054 | SOR-C13 | DB15366 | |
0.5030 | Livoletide | DB15188 |